Article Text

other Versions

PDF
Routine HIV and sexually transmitted infection testing in an abortion service: 6 years’ experience
  1. Rachel Challenor1,
  2. Sarah Challenor2,
  3. Hannah Gregson3,
  4. Sue Pinsent4,5
  1. 1Consultant, Genitourinary Medicine (GUM) Department, Derriford Hospital, Plymouth, UK
  2. 2Medical Senior House Officer, GUM Department, Derriford Hospital, Plymouth, UK
  3. 3Medical Student, Swansea University Medical School, Swansea, UK
  4. 4Associate Specialist, GUM Department, Derriford Hospital, Plymouth, UK
  5. 5Associate Specialist, Pregnancy Advisory Service, Derriford Hospital, Plymouth, UK
  1. Correspondence to Dr Rachel Challenor, Genitourinary Medicine Department, Derriford Hospital, Plymouth PL6 8DH, UK; rachel{at}challenor.biz

Statistics from Altmetric.com

Why is there a need for routine HIV and STI testing in abortion services?

We describe our experience of embedding routine comprehensive HIV and sexually transmitted infection (STI) screening in an abortion service. The British HIV Association (BHIVA) recommended that HIV testing should be offered to all women attending abortion services in the UK National Guidelines for HIV Testing 2008.1 Reducing undiagnosed HIV infection is a public health priority.2 HIV is a treatable medical condition; an individual diagnosed with HIV now should remain fit and well on treatment with a normal/near normal life expectancy.2 Despite this, 24% of the estimated 107 800 people living with HIV in the UK are undiagnosed.2 Whilst unaware of their diagnosis, HIV-positive people are unable to access care to prevent morbidity, mortality and onward transmission of infection. In 2013, 42% of HIV infections were diagnosed late, and this is the greatest cause of mortality in HIV-positive patients nationally.2

The Royal College of Obstetricians and Gynaecologists (RCOG) Guideline, November 2011, on the Care of Women Requesting Induced Abortion3 states that “all women should be screened for Chlamydia trachomatis and undergo a risk assessment for other STIs (e.g. HIV, gonorrhoea, syphilis), and be screened for them if appropriate”. However, universal opt-out HIV testing compared with targeted testing according to risk assessment takes less time per patient,4 results in better uptake of testing5 and is less stigmatising. Opportunities for HIV testing and early diagnosis are currently being missed in women attending abortion services in England6 and will continue to be missed until services offer routine HIV testing instead of targeted HIV testing according to risk assessment.

The impact of STIs remains greatest in young heterosexuals aged <25 years and chlamydia is the most commonly diagnosed STI.7 Other STIs (gonorrhoea and syphilis) are subject to wide geographical variation. However, diagnosing and treating gonorrhoea appropriately …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Highlights from this issue
    British Medical Journal Publishing Group